Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion | MicrobiomeTrials← Back to trialsNCT02858323
Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion
CompletedOBSERVATIONAL
Trial Details
Start: 2016-07-27Est. Completion: 2017-06-20
Enrollment target: 68 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Rifampicin-Resistant Pulmonary TuberculosisMultidrug-Resistant Pulmonary Tuberculosis
This is a Phase 3, randomized, open-label, active-controlled, multicenter trial evaluating the efficacy, safety, and tol…
Beijing, ChinaEst. completion Sep 29, 2028
Atypical Hemolytic Uremic Syndrome(aHUS)
This is a China, non-interventional, observational study and will follow the Good Phar-macoepidemiology Practices guidel…
Beijing, ChinaEst. completion Dec 31, 2027